Eagle Pharmaceuticals Inc (EGRX)
4.55
-0.22
(-4.61%)
USD |
NASDAQ |
Apr 24, 16:00
4.55
0.00 (0.00%)
After-Hours: 20:00
Eagle Pharmaceuticals Free Cash Flow (Quarterly)
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2023 | -0.132M |
| March 31, 2023 | -33.57M |
| December 31, 2022 | 37.55M |
| September 30, 2022 | -13.24M |
| June 30, 2022 | 42.99M |
| March 31, 2022 | -16.78M |
| December 31, 2021 | 8.032M |
| September 30, 2021 | 1.062M |
| June 30, 2021 | 8.708M |
| March 31, 2021 | 10.09M |
| December 31, 2020 | 19.59M |
| September 30, 2020 | 5.426M |
| June 30, 2020 | 21.05M |
| March 31, 2020 | 2.686M |
| December 31, 2019 | -3.331M |
| September 30, 2019 | 10.31M |
| June 30, 2019 | 22.23M |
| March 31, 2019 | 26.00M |
| December 31, 2018 | 38.03M |
| September 30, 2018 | 3.655M |
| June 30, 2018 | 5.667M |
| March 31, 2018 | 4.902M |
| Date | Value |
|---|---|
| December 31, 2017 | 23.19M |
| September 30, 2017 | 6.314M |
| June 30, 2017 | 37.34M |
| March 31, 2017 | -13.11M |
| December 31, 2016 | 33.95M |
| September 30, 2016 | -1.011M |
| June 30, 2016 | -2.724M |
| March 31, 2016 | 2.304M |
| December 31, 2015 | -17.28M |
| September 30, 2015 | -7.706M |
| June 30, 2015 | -12.40M |
| March 31, 2015 | 25.79M |
| December 31, 2014 | -7.886M |
| September 30, 2014 | -7.135M |
| June 30, 2014 | -4.670M |
| March 31, 2014 | -2.099M |
| December 31, 2013 | 0.016M |
| September 30, 2013 | -0.3257M |
| June 30, 2013 | -2.763M |
| March 31, 2013 | -1.022M |
| December 31, 2012 | -1.809M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-33.57M
Minimum
Mar 2023
42.99M
Maximum
Jun 2022
7.216M
Average
8.032M
Median
Dec 2021
Free Cash Flow (Quarterly) Benchmarks
| Inspire Medical Systems Inc | 9.234M |
| Soligenix Inc | -1.828M |
| Marinus Pharmaceuticals Inc | -27.03M |
| NovaBay Pharmaceuticals Inc | -0.316M |
| Palatin Technologies Inc | -10.51M |